Roche’s Susvimo receives US FDA approval for the treatment of diabetic macular edema: Basel Thursday, February 6, 2025, 11:00 Hrs [IST] Roche announced that the US Food and Drug ...
The U.S. Food and Drug Administration has approved Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema.
The goal is to educate the public and professionals about AMD and support patients and families affected by vision impairment ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...